Primary cilia and aberrant cell signaling in epithelial ovarian cancer

Cilia

Volumn 1, Issue , 2012, Pages

  Egeberg, Dorte L ^a,b   Lethan, Mette ^a   Manguso, Robert ^a   Schneider, Linda ^a   Awan, Aashir ^a   Jørgensen, Tue S ^a   Byskov, Anne G ^b   Pedersen, Lotte B ^a   Christensen, Søren T ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b Mental Health Services CPH   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

AURORA A KINASE; CHECKPOINT WITH FORKHEAD ASSOCIATED AND RING FINGER DOMAINS PROTEIN; PLATELET DERIVED GROWTH FACTOR ALPHA RECEPTOR; SMALL INTERFERING RNA; SONIC HEDGEHOG PROTEIN; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELLULAR DISTRIBUTION; CENTROSOME; CONTROLLED STUDY; DOWN REGULATION; EUKARYOTIC FLAGELLUM; FEMALE; GROWTH INHIBITION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE MICROSCOPY; KINETOSOME; OVARY CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; UPREGULATION; WESTERN BLOTTING;

ERINACEIDAE;

EID: 84901268831     PISSN: None     EISSN: 20462530     Source Type: Journal    
DOI: 10.1186/2046-2530-1-15     Document Type: Article

References (95)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin 2010, 60:277-300. 10.3322/caac.20073, 20610543.
2. Aletti GD, Gallenberg MM, Cliby WA, Jatoi A, Hartmann LC. Current management strategies for ovarian cancer. Mayo Clin Proc 2007, 82:751-770.
3. Jelovac D, Armstrong DK. Recent progress in the diagnosis and treatment of ovarian cancer. CA Cancer J Clin 2011, 61:183. 10.3322/caac.20113, 21521830.
4. Aoki Y, Kawada N, Tanaka K. Early form of ovarian cancer originating in inclusion cysts. A case report. J Reprod Med 2000, 45:159-161.
5. Deligdisch L, Einstein AJ, Guera D, Gil J. Ovarian dysplasia in epithelial inclusion cysts. A morphometric approach using neural networks. Cancer 1995, 76:1027-1034. 10.1002/1097-0142(19950915)76:6<1027::AID-CNCR2820760617>3.0.CO;2-6, 8625204.
6. Feeley KM, Wells M. Precursor lesions of ovarian epithelial malignancy. Histopathology 2001, 38:87-95. 10.1046/j.1365-2559.2001.01042.x, 11207821.
7. Bhattacharya R, Kwon J, Ali B, Wang E, Patra S, Shridhar V, Mukherjee P. Role of hedgehog signaling in ovarian cancer. Clin Cancer Res 2008, 14:7659-7666. 10.1158/1078-0432.CCR-08-1414, 19047091.
8. Chen X, Horiuchi A, Kikuchi N, Osada R, Yoshida J, Shiozawa T, Konishi I. Hedgehog signal pathway is activated in ovarian carcinomas, correlating with cell proliferation: its inhibition leads to growth suppression and apoptosis. Cancer Sci 2007, 98:68-76. 10.1111/j.1349-7006.2006.00353.x, 17083567.
9. Liao X, Siu MK, Au CW, Wong ES, Chan HY, Ip PP, Ngan HY, Cheung AN. Aberrant activation of hedgehog signaling pathway in ovarian cancers: effect on prognosis, cell invasion and differentiation. Carcinogenesis 2009, 30:131-140.
10. Schmid S, Bieber M, Zhang F, Zhang M, He B, Jablons D, Teng NN. Wnt and Hedgehog Gene Pathway Expression in Serous Ovarian Cancer. Int J Gynecol Cancer 2011, 21:975-980. 10.1097/IGC.0b013e31821caa6f, 3285558, 21666490.
11. Apte SM, Bucana CD, Killion JJ, Gershenson DM, Fidler IJ. Expression of platelet-derived growth factor and activated receptor in clinical specimens of epithelial ovarian cancer and ovarian carcinoma cell lines. Gynecol Oncol 2004, 93:78-86. 10.1016/j.ygyno.2003.12.041, 15047217.
12. Henriksen R, Funa K, Wilander E, Backstrom T, Ridderheim M, Oberg K. Expression and prognostic significance of platelet-derived growth factor and its receptors in epithelial ovarian neoplasms. Cancer Res 1993, 53:4550-4554.
13. Lassus H, Sihto H, Leminen A, Nordling S, Joensuu H, Nupponen NN, Butzow R. Genetic alterations and protein expression of KIT and PDGFRA in serous ovarian carcinoma. Br J Cancer 2004, 91:2048-2055. 10.1038/sj.bjc.6602252, 2409787, 15583695.
14. Matei D, Emerson RE, Lai YC, Baldridge LA, Rao J, Yiannoutsos C, Donner DD. Autocrine activation of PDGFRalpha promotes the progression of ovarian cancer. Oncogene 2006, 25:2060-2069. 10.1038/sj.onc.1209232, 16331269.
15. Gritsko TM, Coppola D, Paciga JE, Yang L, Sun M, Shelley SA, Fiorica JV, Nicosia SV, Cheng JQ. Activation and overexpression of centrosome kinase BTAK/Aurora-A in human ovarian cancer. Clin Cancer Res 2003, 9:1420-1426.
16. Hu W, Kavanagh JJ, Deaver M, Johnston DA, Freedman RS, Verschraegen CF, Sen S. Frequent overexpression of STK15/Aurora-A/BTAK and chromosomal instability in tumorigenic cell cultures derived from human ovarian cancer. Oncol Res 2005, 15:49-57.
17. Landen CN. Lin YG, Immaneni A, Deavers MT, Merritt WM, Spannuth WA, Bodurka DC, Gershenson DM, Brinkley WR, Sood AK: Overexpression of the centrosomal protein Aurora-A kinase is associated with poor prognosis in epithelial ovarian cancer patients. Clin Cancer Res 2007, 13:4098-4104. 10.1158/1078-0432.CCR-07-0431, 17634535.
18. Tanner MM, Grenman S, Koul A, Johannsson O, Meltzer P, Pejovic T, Borg A, Isola JJ. Frequent amplification of chromosomal region 20q12-q13 in ovarian cancer. Clin Cancer Res 2000, 6:1833-1839.
19. Gao Y, Lou G, Zhang GM, Sun XW, Ma YY, Yang YM, Liu G. CHFR promoter hypermethylation and reduced CHFR mRNA expression in ovarian cancer. Int J Biol Markers 2009, 24:83-89.
20. Campos SM, Ghosh S. A current review of targeted therapeutics for ovarian cancer. J Oncol 2010, 201:149362.
21. Jiang J, Hui C. Hedgehog signaling in development and cancer. Dev Cell 2008, 15:801-812. 10.1016/j.devcel.2008.11.010, 19081070.
22. Lai K, Kaspar BK, Gage FH, Schaffer DV. Sonic hedgehog regulates adult neural progenitor proliferation in vitro and in vivo. Nat Neurosci 2003, 6:21-27. 10.1038/nn983, 12469128.
23. Liu S, Dontu G, Mantle ID, Patel S, Ahn N, Jackson KW, Suri P, Wicha MS. Hedgehog signaling and Bmi-1 regulate self-renewal of normal and malignant human mammary stem cells. Cancer Res 2006, 66:6063-6071. 10.1158/0008-5472.CAN-06-0054, 16778178.
24. Lipinski RJ, Gipp JJ, Zhang J, Doles JD, Bushman W. Unique and complimentary activities of the Gli transcription factors in Hedgehog signaling. Exp Cell Res 2006, 312:1925-1938. 10.1016/j.yexcr.2006.02.019, 16571352.
25. Rohatgi R, Milenkovic L, Scott MP. Patched1 regulates hedgehog signaling at the primary cilium. Science 2007, 317:372-376. 10.1126/science.1139740, 17641202.
26. Heldin CH, Westermark B. Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283-1316.
27. Fu J, Bian M, Jiang Q, Zhang C. Roles of Aurora kinases in mitosis and tumorigenesis. Mol Cancer Res 2007, 5:1-10. 10.1158/1541-7786.MCR-06-0208, 17259342.
28. Chung CM, Man C, Jin Y, Jin C, Guan XY, Wang Q, Wan TS, Cheung AL, Tsao SW. Amplification and overexpression of aurora kinase A (AURKA) in immortalized human ovarian epithelial (HOSE) cells. Mol Carcinog 2005, 43:165-174. 10.1002/mc.20098, 15880741.
29. Kang D, Chen J, Wong J, Fang G. The checkpoint protein Chfr is a ligase that ubiquitinates Plk1 and inhibits Cdc2 at the G2 to M transition. J Cell Biol 2002, 156:249-259. 10.1083/jcb.200108016, 2199220, 11807090.
30. Privette LM, Petty EM. CHFR: a novel mitotic checkpoint protein and regulator of tumorigenesis. Transl Oncol 2008, 1:57-64. 2510817, 18633460.
31. Privette LM, Weier JF, Nguyen HN, Yu X, Petty EM. Loss of CHFR in human mammary epithelial cells causes genomic instability by disrupting the mitotic spindle assembly checkpoint. Neoplasia 2008, 10:643-652. 2435002, 18592005.
32. Yu X, Minter-Dykhouse K, Malureanu L, Zhao WM, Zhang D, Merkle CJ, Ward IM, Saya H, Fang G, van Deursen J, Chen J. Chfr is required for tumor suppression and Aurora A regulation. Nat Genet 2005, 37:401-406. 10.1038/ng1538, 15793587.
33. Mans DA, Voest EE, Giles RH. All along the watchtower: is the cilium a tumor suppressor organelle?. Biochim Biophys Acta 2008, 1786:114-125.
34. Plotnikova OV, Golemis EA, Pugacheva EN. Cell cycle-dependent ciliogenesis and cancer. Cancer Res 2008, 68:2058-2061. 10.1158/0008-5472.CAN-07-5838, 2546565, 18381407.
35. Satir P, Pedersen LB, Christensen ST. The primary cilium at a glance. J Cell Sci 2010, 123:499-503. 10.1242/jcs.050377, 2818190, 20144997.
36. Christensen ST, Clement CA, Satir P, Pedersen LB. Primary cilia and coordination of receptor tyrosine kinase (RTK) signaling. J Pathol 2011, 226:172-184.
37. Goetz SC, Anderson KV. The primary cilium: a signalling centre during vertebrate development. Nat Rev Genet 2010, 11:331-344. 10.1038/nrg2774, 3121168, 20395968.
38. Christensen ST, Ott CM. Cell signaling. A ciliary signaling switch. Science 2007, 317:330-331. 10.1126/science.1146180, 17641189.
39. Wallingford JB, Mitchell B. Strange as it may seem: the many links between Wnt signaling, planar cell polarity, and cilia. Genes Dev 2011, 25:201-213. 10.1101/gad.2008011, 3034894, 21289065.
40. Fliegauf M, Benzing T, Omran H. When cilia go bad: cilia defects and ciliopathies. Nat Rev Mol Cell Biol 2007, 8:880-893. 10.1038/nrm2278, 17955020.
41. Hildebrandt F, Benzing T, Katsanis N. Ciliopathies. N Engl J Med 2011, 364:1533-1543. 10.1056/NEJMra1010172, 21506742.
42. Han YG, Kim HJ, Dlugosz AA, Ellison DW, Gilbertson RJ, Alvarez-Buylla A. Dual and opposing roles of primary cilia in medulloblastoma development. Nat Med 2009, 15:1062-1065. 10.1038/nm.2020, 2771737, 19701203.
43. Moser JJ, Fritzler MJ, Rattner JB. Primary ciliogenesis defects are associated with human astrocytoma/ glioblastoma cells. BMC Cancer 2009, 9:448. 10.1186/1471-2407-9-448, 2806408, 20017937.
44. Seeley ES, Carriere C, Goetze T, Longnecker DS, Korc M. Pancreatic cancer and precursor pancreatic intraepithelial neoplasia lesions are devoid of primary cilia. Cancer Res 2009, 69:422-430. 10.1158/0008-5472.CAN-08-1290, 2629528, 19147554.
45. Yuan K, Frolova N, Xie Y, Wang D, Cook L, Kwon YJ, Steg AD, Serra R, Frost AR. Primary cilia are decreased in breast cancer: analysis of a collection of human breast cancer cell lines and tissues. J Histochem Cytochem 2010, 58:857-870. 10.1369/jhc.2010.955856, 2942739, 20530462.
46. Wong SY, Seol AD, So PL, Ermilov AN, Bichakjian CK, Epstein EH, Dlugosz AA, Reiter JF. Primary cilia can both mediate and suppress Hedgehog pathway-dependent tumorigenesis. Nat Med 2009, 15:1055-1061. 10.1038/nm.2011, 2895420, 19701205.
47. Zhang J, Lipinski RJ, Gipp JJ, Shaw AK, Bushman W. Hedgehog pathway responsiveness correlates with the presence of primary cilia on prostate stromal cells. BMC Dev Biol 2009, 9:50. 10.1186/1471-213X-9-50, 2767347, 19811645.
48. Montani M, Heinimann K, von Teichman A, Rudolph T, Perren A, Moch H. VHL-gene deletion in single renal tubular epithelial cells and renal tubular cysts: further evidence for a cyst-dependent progression pathway of clear cell renal carcinoma in von Hippel-Lindau disease. Am J Surg Pathol 2010, 34:806-881. 10.1097/PAS.0b013e3181ddf54d, 20431476.
49. de Andrea CE, Wiweger M, Prins F, Bovee JV, Romeo S, Hogendoorn PC. Primary cilia organization reflects polarity in the growth plate and implies loss of polarity and mosaicism in osteochondroma. Lab Invest 2010, 90:1091-1101. 10.1038/labinvest.2010.81, 20421870.
50. Zhang J, Lipinski R, Shaw A, Gipp J, Bushman W. Lack of demonstrable autocrine hedgehog signaling in human prostate cancer cell lines. J Urol 2007, 177:1179-1185. 10.1016/j.juro.2006.10.032, 17296441.
51. Reiter R, Gais P, Jutting U, Steuer-Vogt MK, Pickhard A, Bink K, Rauser S, Lassmann S, Höfler H, Werner M, Walch A. Aurora kinase A messenger RNA overexpression is correlated with tumor progression and shortened survival in head and neck squamous cell carcinoma. Clin Cancer Res 2006, 12:5136-5141. 10.1158/1078-0432.CCR-05-1650, 16951231.
52. Shang X, Burlingame SM, Okcu MF, Ge N, Russell HV, Egler RA, David RD, Vasudevan SA, Yang J, Nuchtern JG. Aurora A is a negative prognostic factor and a new therapeutic target in human neuroblastoma. Mol Cancer Ther 2009, 8:2461-2469. 10.1158/1535-7163.MCT-08-0857, 19671766.
53. Jeng YM, Peng SY, Lin CY, Hsu HC. Overexpression and amplification of Aurora-A in hepatocellular carcinoma. Clin Cancer Res 2004, 10:2065-2071. 10.1158/1078-0432.CCR-1057-03, 15041727.
54. Pugacheva EN, Jablonski SA, Hartman TR, Henske EP, Golemis EA. HEF1-dependent aurora A activation induces disassembly of the primary cilium. Cell 2007, 129:1351-1363. 10.1016/j.cell.2007.04.035, 2504417, 17604723.
55. Auersperg N, Maines-Bandiera SL, Dyck HG. Ovarian carcinogenesis and the biology of ovarian surface epithelium. J Cell Physiol 1997, 173:261-265. 10.1002/(SICI)1097-4652(199711)173:2<261::AID-JCP32>3.0.CO;2-G, 9365533.
56. Teilmann SC, Christensen ST. Localization of the angiopoietin receptors Tie-1 and Tie-2 on the primary cilia in the female reproductive organs. Cell Biol Int 2005, 29:340-346. 10.1016/j.cellbi.2005.03.006, 15893943.
57. Auersperg N, Siemens CH, Myrdal SE. Human ovarian surface epithelium in primary culture. In Vitro 1984, 20:743-755. 10.1007/BF02618290, 6083974.
58. Auersperg N, Maines-Bandiera SL, Dyck HG, Kruk PA. Characterization of cultured human ovarian surface epithelial cells: phenotypic plasticity and premalignant changes. Lab Invest 1994, 71:510-518.
59. Wong AS, Maines-Bandiera SL, Rosen B, Wheelock MJ, Johnson KR, Leung PC, Roskelley CD, Auersperg N. Constitutive and conditional cadherin expression in cultured human ovarian surface epithelium: influence of family history of ovarian cancer. Int J Cancer 1999, 81:180-188. 10.1002/(SICI)1097-0215(19990412)81:2<180::AID-IJC3>3.0.CO;2-7, 10188716.
60. Kruk PA, Maines-Bandiera SL, Auersperg N. A simplified method to culture human ovarian surface epithelium. Lab Invest 1990, 63:132-136.
61. Fogh J, Trempe G. New human tumor cell lines. Human Tumor Cells in Vitro 1975, 115-159. Plenum Press, New York, Fogh J.
62. Hamilton TC, Young RC, McKoy WM, Grotzinger KR, Green JA, Chu EW, Whang-Peng J, Rogan AM, Green WR, Ozols RF. Characterization of a human ovarian carcinoma cell line (NIH:OVCAR-3) with androgen and estrogen receptors. Cancer Res 1983, 43:5379-5389.
63. Buick RN, Pullano R, Trent JM. Comparative properties of five human ovarian adenocarcinoma cell lines. Cancer Res 1985, 45:3668-3676.
64. Dyck HG, Hamilton TC, Godwin AK, Lynch HT, Maines-Bandiera S, Auersperg N. Autonomy of the epithelial phenotype in human ovarian surface epithelium: changes with neoplastic progression and with a family history of ovarian cancer. Int J Cancer 1996, 69:429-436. 10.1002/(SICI)1097-0215(19961220)69:6<429::AID-IJC1>3.0.CO;2-6, 8980241.
65. Ong A, Maines-Bandiera SL, Roskelley CD, Auersperg N. An ovarian adenocarcinoma line derived from SV40/E-cadherin-transfected normal human ovarian surface epithelium. Int J Cancer 2000, 85:430-437. 10.1002/(SICI)1097-0215(20000201)85:3<430::AID-IJC21>3.0.CO;2-Q, 10652437.
66. Pedersen LB, Veland IR, Schroder JM, Christensen ST. Assembly of primary cilia. Dev Dyn 2008, 237:1993-2006. 10.1002/dvdy.21521, 18393310.
67. Clement CA, Kristensen SG, Mollgard K, Pazour GJ, Yoder BK, Larsen LA, Christensen ST. The primary cilium coordinates early cardiogenesis and hedgehog signaling in cardiomyocyte differentiation. J Cell Sci 2009, 122:3070-3082. 10.1242/jcs.049676, 2729259, 19654211.
68. Follit JA, Tuft RA, Fogarty KE, Pazour GJ. The intraflagellar transport protein IFT20 is associated with the Golgi complex and is required for cilia assembly. Mol Biol Cell 2006, 17:3781-3792. 10.1091/mbc.E06-02-0133, 1593158, 16775004.
69. Pazour GJ, Dickert BL, Vucica Y, Seeley ES, Rosenbaum JL, Witman GB, Cole DG. Chlamydomonas IFT88 and its mouse homologue, polycystic kidney disease gene tg737, are required for assembly of cilia and flagella. J Cell Biol 2000, 151:709-718. 10.1083/jcb.151.3.709, 2185580, 11062270.
70. Haycraft CJ, Banizs B, Aydin-Son Y, Zhang Q, Michaud EJ, Yoder BK. Gli2 and Gli3 localize to cilia and require the intraflagellar transport protein polaris for processing and function. PLoS Genet 2005, 1:e53. 10.1371/journal.pgen.0010053, 1270009, 16254602.
71. Pan Y, Bai CB, Joyner AL, Wang B. Sonic hedgehog signaling regulates Gli2 transcriptional activity by suppressing its processing and degradation. Mol Cell Biol 2006, 26:3365-3377. 10.1128/MCB.26.9.3365-3377.2006, 1447407, 16611981.
72. Sasaki H, Nishizaki Y, Hui C, Nakafuku M, Kondoh H. Regulation of Gli2 and Gli3 activities by an amino-terminal repression domain: implication of Gli2 and Gli3 as primary mediators of Shh signaling. Development 1999, 126:3915-3924.
73. Lih CJ, Cohen SN, Wang C, Lin-Chao S. The platelet-derived growth factor alpha-receptor is encoded by a growth-arrest-specific (gas) gene. Proc Natl Acad Sci U S A 1996, 93:4617-4622. 10.1073/pnas.93.10.4617, 39327, 8643452.
74. Schneider L, Clement CA, Teilmann SC, Pazour GJ, Hoffmann EK, Satir P, Christensen ST. PDGFRalphaalpha signaling is regulated through the primary cilium in fibroblasts. Curr Biol 2005, 15:1861-1866. 10.1016/j.cub.2005.09.012, 16243034.
75. Schneider L, Cammer M, Lehman J, Nielsen SK, Guerra CF, Veland IR, Stock C, Hoffmann EK, Yoder BK, Schwab A, Satir P, Christensen ST. Directional cell migration and chemotaxis in wound healing response to PDGF-AA are coordinated by the primary cilium in fibroblasts. Cell Physiol Biochem 2010, 25:279-292. 10.1159/000276562, 2924811,2924811, 20110689.
76. Pan J, Wang Q, Snell WJ. An aurora kinase is essential for flagellar disassembly in Chlamydomonas. Dev Cell 2004, 6:445-451. 10.1016/S1534-5807(04)00064-4, 15030766.
77. Pugacheva EN, Golemis EA. The focal adhesion scaffolding protein HEF1 regulates activation of the aurora-A and Nek2 kinases at the centrosome. Nat Cell Biol 2005, 7:937-946. 10.1038/ncb1309, 2652766, 16184168.
78. Kwon YE, Kim YS, Oh YM, Seol JH. Nuclear localization of Chfr is crucial for its checkpoint function. Mol Cells 2009, 27:359-363. 10.1007/s10059-009-0046-7, 19326084.
79. Oh YM, Yoo SJ, Seol JH. Deubiquitination of Chfr, a checkpoint protein, by USP7/HAUSP regulates its stability and activity. Biochem Biophys Res Commun 2007, 357:615-619. 10.1016/j.bbrc.2007.03.193, 17442268.
80. Daniels MJ, Marson A, Venkitaraman AR. PML bodies control the nuclear dynamics and function of the CHFR mitotic checkpoint protein. Nat Struct Mol Biol 2004, 11:1114-1121. 10.1038/nsmb837, 15467728.
81. Castiel A, Danieli MM, David A, Moshkovitz S, Aplan PD, Kirsch IR, Brandeis M, Krämer A, Izraeli S. The Stil protein regulates centrosome integrity and mitosis through suppression of Chfr. J Cell Sci 2011, 124:532. 10.1242/jcs.079731, 3031367, 21245198.
82. Burgess A, Labbe JC, Vigneron S, Bonneaud N, Strub JM, Van Dorsselaer A, Lorca T, Castro A. Chfr interacts and colocalizes with TCTP to the mitotic spindle. Oncogene 2008, 27:5554-5566. 10.1038/onc.2008.167, 18504434.
83. Xu J, Li H, Wang B, Xu Y, Yang J, Zhang X, Harten SK, Shukla D, Maxwell PH, Pei D, Esteban MA. VHL inactivation induces HEF1 and aurora kinase A. J Am Soc Nephrol 2010, 21:2041-2046. 10.1681/ASN.2010040345, 3014016, 20864688.
84. Nielsen SK, Mollgard K, Clement CA, Veland IR, Awan A, Yoder BK, Novak I, Christensen ST. Characterization of primary cilia and Hedgehog signaling during development of the human pancreas and in human pancreatic duct cancer cell lines. Dev Dyn 2008, 237:2039-2052. 10.1002/dvdy.21610, 18629868.
85. Privette LM, Gonzalez ME, Ding L, Kleer CG, Petty EM. Altered expression of the early mitotic checkpoint protein, CHFR, in breast cancers: implications for tumor suppression. Cancer Res 2007, 67:6064-6074. 10.1158/0008-5472.CAN-06-4109, 17596595.
86. Toyota M, Sasaki Y, Satoh A, Ogi K, Kikuchi T, Suzuki H, Mita H, Tanaka N, Itoh F, Issa JP, Jair KW, Schuebel KE, Imai K, Tokino T. Epigenetic inactivation of CHFR in human tumors. Proc Natl Acad Sci U S A 2003, 100:7818-7823. 10.1073/pnas.1337066100, 164671, 12810945.
87. Scolnick DM, Halazonetis TD. Chfr defines a mitotic stress checkpoint that delays entry into metaphase. Nature 2000, 406:430-435. 10.1038/35019108, 10935642.
88. Hubbert C, Guardiola A, Shao R, Kawaguchi Y, Ito A, Nixon A, Yoshida M, Wang XF, Yao TP. HDAC6 is a microtubule-associated deacetylase. Nature 2002, 417:455-458. 10.1038/417455a, 12024216.
89. Haggarty SJ, Koeller KM, Wong JC, Grozinger CM, Schreiber SL. Domain-selective small-molecule inhibitor of histone deacetylase 6 (HDAC6)-mediated tubulin deacetylation. Proc Natl Acad Sci U S A 2003, 100:4389-4394. 10.1073/pnas.0430973100, 153564, 12677000.
90. Matsuyama A, Shimazu T, Sumida Y, Saito A, Yoshimatsu Y, Seigneurin-Berny D, Osada H, Komatsu Y, Nishino N, Khochbin S, Horinouchi S, Yoshida M. In vivo destabilization of dynamic microtubules by HDAC6-mediated deacetylation. EMBO J 2002, 21:6820-6831. 10.1093/emboj/cdf682, 139102, 12486003.
91. Sharma N, Kosan ZA, Stallworth JE, Berbari NF, Yoder BK. Soluble levels of cytosolic tubulin regulate ciliary length control. Mol Biol Cell 2011, 22:806-816. 10.1091/mbc.E10-03-0269, 3057705, 21270438.
92. Zhang Y, Kwon SH, Yamaguchi T, Cubizolles F, Rousseaux S, Kneissel M, Cao C, Li N, Cheng HL, Chua K, Lombard D, Mizeracki A, Matthias G, Alt FW, Khochbin S, Matthias P. Mice lacking histone deacetylase 6 have hyperacetylated tubulin but are viable and develop normally. Mol Cell Biol 2008, 28:1688-1701. 10.1128/MCB.01154-06, 2258784, 18180281.
93. Schrøder JM, Larsen J, Komarova Y, Akhmanova A, Thorsteinsson RI, Grigoriev I, Manguso R, Christensen ST, Pedersen SF, Geimer S, Pedersen LB. EB1 and EB3 promote cilia biogenesis by several centrosome-related mechanisms. J Cell Sci 2011, 124:2539-2551. 10.1242/jcs.085852, 3138699, 21768326.
94. Christensen ST, Guerra C, Wada Y, Valentin T, Angeletti RH, Satir P, Hamasaki T. A regulatory light chain of ciliary outer arm dynein in Tetrahymena thermophila. J Biol Chem 2001, 276:20048-20054. 10.1074/jbc.M008412200, 11274140.
95. Rompolas P, Pedersen LB, Patel-King RS, King SM. Chlamydomonas FAP133 is a dynein intermediate chain associated with the retrograde intraflagellar transport motor. J Cell Sci 2007, 120:3653-3665. 10.1242/jcs.012773, 17895364.